Literature DB >> 6135698

Development of tyrosine aminotransferase in perinatal rat liver: changes in functional messenger RNA and the role of inducing hormones.

S T Perry, R Rothrock, K R Isham, K L Lee, F T Kenney.   

Abstract

Expression of the hepatic enzyme tyrosine aminotransferase was analyzed in the perinatal period of development in the rat, when this expression undergoes significant changes associated with hepatocyte differentiation. In late prenatal liver both enzyme and functional mRNA gene products are present at levels 10- to 15-fold below those in the fully differentiated adult liver. This low level of expression in fetal liver is refractory to induction by glucocorticoids, but both gene products are increased to a limited extent by cyclic AMP. This induction by cyclic AMP (cAMP) does not confer glucocorticoid-responsiveness on expression. By 3 hr after birth both functional mRNA and enzyme levels are significantly increased, an increase which continues until a peak is reached at 12 hr that is appreciably above the adult levels. Both gene products then decline until adult levels are reached by 24 hr. The postnatal shift in aminotransferase expression is accompanied by acquisition of the capacity to respond to glucocorticoids. Treatment of newborns with an antiglucocorticoid steroid or with glucose suppresses the postnatal overshoot of expression, but neither treatment affects the increase from fetal to adult levels of expression. The results indicate that prior to birth, expression of the aminotransferase gene is partially repressed, a repression that is lifted essentially immediately upon birth. The hormones capable of inducing aminotransferase synthesis have no apparent necessary role in this process.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6135698     DOI: 10.1002/jcb.240210107

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  8 in total

1.  The glucocorticoid hormone signal transduction pathway in mice homozygous for chromosomal deletions causing failure of cell type-specific inducible gene expression.

Authors:  D DeFranco; D Bali; R Torres; R A DePinho; R P Erickson; S Gluecksohn-Waelsch
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-01       Impact factor: 11.205

2.  Induction of tyrosine aminotransferase in utero by anti-insulin agents.

Authors:  M H Cake
Journal:  Biochem J       Date:  1986-09-15       Impact factor: 3.857

3.  Hepatic differentiation induced by oncostatin M attenuates fetal liver hematopoiesis.

Authors:  T Kinoshita; T Sekiguchi; M J Xu; Y Ito; A Kamiya; K Tsuji; T Nakahata; A Miyajima
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-22       Impact factor: 11.205

4.  Characterization of the rat developmental liver transcriptome.

Authors:  Richard H Chapple; Polyana C Tizioto; Kevin D Wells; Scott A Givan; JaeWoo Kim; Stephanie D McKay; Robert D Schnabel; Jeremy F Taylor
Journal:  Physiol Genomics       Date:  2013-02-19       Impact factor: 3.107

5.  Hepatocyte differentiation in vitro: initiation of tyrosine aminotransferase expression in cultured fetal rat hepatocytes.

Authors:  L L Shelly; W Tynan; W Schmid; G Schütz; G C Yeoh
Journal:  J Cell Biol       Date:  1989-12       Impact factor: 10.539

6.  Hepatic metabolomic profiling changes along with postnatal liver maturation in breeder roosters.

Authors:  Shengru Wu; Yanli Liu; Liqin Zhu; Di Han; Musa Bello Bodinga; Xiaojun Yang
Journal:  Biol Open       Date:  2018-01-22       Impact factor: 2.422

7.  The basic helix-loop-helix transcription factor, Mist1, induces maturation of mouse fetal hepatoblasts.

Authors:  Hiromi Chikada; Keiichi Ito; Ayaka Yanagida; Hiromitsu Nakauchi; Akihide Kamiya
Journal:  Sci Rep       Date:  2015-10-12       Impact factor: 4.379

8.  Foetal hepatic progenitor cells assume a cholangiocytic cell phenotype during two-dimensional pre-culture.

Authors:  Kazuya Anzai; Hiromi Chikada; Kota Tsuruya; Kinuyo Ida; Tatehiro Kagawa; Yutaka Inagaki; Tesuya Mine; Akihide Kamiya
Journal:  Sci Rep       Date:  2016-06-23       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.